Key facts
- This page summarizes Nicole Sandford's Form 4 filing for Aspira Women's Health Inc. (AWHL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 May 2024, 19:18.
Nicole Sandford - 13 May 2024 Form 4 Insider Report for Aspira Women's Health Inc. (AWHL)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- AWHL
- Reported as of
- 13 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 May 2024, 19:18:13 UTC
- Prior SEC filing
- 20 Feb 2024
- Next SEC filing
- 03 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nicole Sandford
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Nicole Sandford filed Form 4 for Aspira Women's Health Inc. (AWHL) on 14 May 2024.
Change
- Previous filing in this sequence was filed on 20 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AWH
transaction
Derivative
EMPLOYEE STOCK OPTION (RIGHT TO BUY)
Award
- Transaction value
- $0
- Shares
- +80,000
- Change %
- Price
- $0.000000
- Shares after
- 80,000
- Date
- 13 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,000
- Exercise price
- $2.88
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The employee stock option will vest in equal monthly installments over four years beginning June 13, 2024.